Business of Optometry News

ATSN-201 received orphan drug designation from the FDA for the treatment of X-linked retinoschisis, according to a press release from Atsena Therapeutics.

ANI Pharmaceuticals finalized its acquisition of Alimera Sciences, according to a press release.

Saving money at an early age is perhaps the simplest and one of the most effective methods to accumulate wealth.

Sonoma Pharmaceuticals and EMC Pharma have entered into a co-marketing agreement to expand their eye care product lines, according to a press release.

The FDA granted 510(k) clearance for OCT angiography on the robotic Maestro2 OCT color fundus camera system, according to a press release from Topcon Healthcare.

Viridian Therapeutics reported positive topline data from the phase 3 THRIVE clinical trial of veligrotug for the treatment of active thyroid eye disease.

ThinOptics, a manufacturer of ultra-slim reading glasses, has launched its Prescription on Demand service for purchase of customized prescription eye wear online, the company announced in a press release.

One important investment vehicle to understand when working toward slow and steady growth is the index fund.

Ocuphire Pharma has dosed the first participants in the VEGA-3 phase 3 clinical trial investigating phentolamine ophthalmic solution 0.75% for the treatment of presbyopia, according to a press release.